Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
HospitalsIndependent Academic Research Groups

Sheba Medical Center

Israel
9 Trials

Israel's largest hospital and a major academic medical center affiliated with Tel Aviv University. A key site for MDMA-assisted psychotherapy trials through MAPS Israel and other research programs, as well as ketamine studies for treatment-resistant depression.

Quick Facts

Type
Other
HQ
Israel
Website
Visit

Sponsored Trials

8
Not yet recruiting

Mitochondrial Function After Ketamine

Start Date
February 1, 2026
Compounds
Ketamine
CompletedIV

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Start Date
December 6, 2022
Compounds
Ketamine
Unknown statusNA

Ketamine Long Term Follow Up Study

Start Date
December 14, 2019
CompletedNA

Ketamine IV Classic Protocol : Five Years Follow up

Start Date
August 8, 2019
Compounds
Ketamine
WithdrawnI

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Start Date
August 15, 2016
Compounds
Ketamine, Placebo
Unknown statusIV

D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression

Start Date
June 1, 2016
Compounds
Ketamine, Placebo
Unknown statusNA

Ketamine Infusions for Major Depression Disorder

Start Date
January 8, 2014
Compounds
Ketamine
TerminatedIV

The Effects of Ketamine and Methadone on Postoperative Pain for Laminectomy

Start Date
February 1, 2013
Compounds
Ketamine, Placebo

Collaborated Trials

1
CompletedNA

The NeXT Study

Start Date
April 1, 2002

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.